article thumbnail

Cipla Vs Sun Pharmaceutical – Financials, Future Plans & More

Trade Brains

Cipla Vs Sun Pharmaceutical : Pharma companies bear enormous responsibility for producing medicines and monetizing the time and effort spent on research and development for years by using patent protection. Sun Pharma’s portfolio includes innovative specialty medicines, branded generics, pure generics, and APIs.

article thumbnail

Fundamental Analysis Of Lupin – Industry Analysis and Financials

Trade Brains

Fundamental Analysis Of Lupin : Medicines are substances that can be used to prevent, treat, or cure disease. Pharmaceutical companies in India have come a long way in supplying medicines, and with more research, they are improving their products. Segment Analysis The company’s revenue was Rs. crore in FY23.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fundamental Analysis Of Zydus Lifesciences – Financials & More Details

Trade Brains

Industry Overview India is the 12th-largest market in terms of value and the world’s third-largest pharmaceutical manufacturer in terms of volume. The Indian pharmaceutical sector includes over-the-counter medicines, generic medications, bulk drugs, vaccines, contract research and manufacture, biosimilars, and biologics.

article thumbnail

High FII Holding Stocks Under Rs 500 To Add To Your Watchlist

Trade Brains

High FII Holding Stocks under Rs 500 : Any country in the world welcomes any capital brought or invested in by foreign institutions because it can help companies invest in capex, R&D, and strategic stakes, which are some of the factors that make FII stakes appealing in the shareholding of any company. crore in FY22. crore from Rs.

article thumbnail

Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More

Trade Brains

It is the world’s largest supplier of generic medicine, in terms of volume with a 20% market share. According to the Economic Survey 2023, India’s domestic pharmaceutical market was estimated at $41 billion. As per IQVIA report, the global medicine market is expected to reach USD 1.9

article thumbnail

Motel 6 or Four Seasons? Preparing, Not Panicking, for Retirement

Investing Caffeine

Rather than constantly scrolling through headlines on your mobile phone news app, here are some areas of focus and questions you should be asking yourself: · Investment Strategy: What type of investment strategy should you be utilizing to reach your retirement goals? Diversification: How diversified are your investments?

article thumbnail

Best Dividend Stocks Under Rs 1000 – Analysis & Top Picks

Trade Brains

(UTI AMC) is an Indian asset management company engaged in the business of raising funds for and rendering investment management services to schemes of UTI Mutual Fund. D/E Ratio 0 Dividend Yield 2.66% Net Profit Margin 38.9 % Operating Profit Margin 54.2 % UTI AMC is a small-cap company with a market capitalization of ₹10,425 crores.